NIFTYPHARMA · NSE
Nifty Pharma
Index · View only — not on the trading terminal
₹26,710.1
+0.49% (+₹130.85)
Prev. close
₹26,579.25
Volume
3,11,76,682
As of
18 Sept 2026
Price history
Rohit Srivastava · Strike Money Analytics and Indiacharts · 11 Mar 2026
“Rohit Srivastava views the pharmaceutical sector as a pure defensive bet during difficult markets. He suggests pharma stocks can provide stability and act as a hedge, making them an area to consider amidst broader market volatility.”
Published mid-session at 13:38 IST. Tracking counts only prices printed after publication — the chart's dashed divider marks that moment; earlier prices never count toward entry or results.
Analyst sentiment
Analysts lean bullish
7 analyst stances · last 90 days · one per analyst
Trackable
2 · 2 bull / 0 neutral / 0 bear
Long-Horizon
none in window
Commentary
5 · 3 bull / 1 neutral / 1 bear
Trackable = verdict-bearing calls · Long-Horizon = 1yr+ horizon, verdict pending · Commentary = context, not graded
Analyst opinions
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “Bullish on smaller CDMO (Contract Development and Manufacturing Organisation) companies, expecting them to deliver stron…” | Vishal ManchandaSystematix Group | Nifty Pharma | PENDING | |
| “Bullish on Pharma and CDMO stocks, observing that they continue to find buyers despite elevated valuations. This indicat…” | VK VijayakumarGeojit Investments | Pharma and CDMO | PENDING |
Market commentary · 5 · levels, conditionals, previews, macro & hedged views — context, not graded
| Call | Analyst | Instrument | Verdict | Actions |
|---|---|---|---|---|
| “The proposed US tariffs on imported generic medicines create uncertainty for Indian pharmaceutical exporters. While ther…” | Sunny AgrawalSBI Cap Securities | Nifty Pharma | NOT GRADED | |
| “The proposed US tariffs on generic imports, which are not India-specific, are unlikely to significantly impact Indian ph…” | Tushar ManudhaneMotilal Oswal Financial Services | Nifty Pharma | PENDING | |
| “Pharma remains one of the strongest performing sectors, supported by a clear higher-high, higher-low formation and susta…” | Hitesh TailorChoice Equity Broking | Nifty Pharma | NOT GRADED | |
| “Bullish on the Pharma sector, which has broken out of an 18-month consolidation and hit a fresh All-time High. The secto…” | Dharmesh ShahICICI Securities | Nifty Pharma | PENDING | |
| “Pharma is a better dollar play than IT in the current environment, driven by three tailwinds: FII flows, product-specifi…” | Sunil SubramaniamSense and Simplicity | Nifty Pharma | HIT |
Index metrics
As of 19 Sept, 06:24 IST
Open
26,613.55
Day High
26,849
Day Low
26,598.75
Prev. Close
26,579.25
52W High
27,188.45
52W Low
21,149.9
P/E
41.36
P/B
5.02
Div. Yield
0.53%
Member stocks today
How many of this index's member stocks rose or fell today — a broad move and a few-heavyweights move look very different here.
17
Rose
3
Fell
0
Flat
Composition
20 stocks · 17 advanced · 3 declined
Member stocks, ranked by index weight — heaviest first.
Top weight: SUNPHARMA · 19.6% (free-float mcap share, estimate — not NSE’s published weight)
SUNPHARMA
Sun Pharmaceutical Industries Ltd. · Healthcare
19.6%
₹1,837.3
-1.61%
DIVISLAB
Divi's Laboratories Ltd. · Healthcare
12.0%
₹9,375
+0.56%
CIPLA
Cipla Ltd. · Healthcare
7.9%
₹1,394.5
+1.32%
LAURUSLABS
Laurus Labs Ltd. · Healthcare
7.7%
₹1,954
+0.30%
DRREDDY
Dr. Reddy's Laboratories Ltd. · Healthcare
7.3%
₹1,185
+0.85%
TORNTPHARM
Torrent Pharmaceuticals Ltd. · Healthcare
7.1%
₹4,840
-0.72%
LUPIN
Lupin Ltd. · Healthcare
5.1%
₹2,083
-0.72%
AUROPHARMA
Aurobindo Pharma Ltd. · Healthcare
4.8%
₹1,734
+2.60%
GLENMARK
Glenmark Pharmaceuticals Ltd. · Healthcare
3.7%
₹2,447.4
+1.30%
ALKEM
Alkem Laboratories Ltd. · Healthcare
3.2%
₹5,466.5
+2.21%
ZYDUSLIFE
Zydus Lifesciences Ltd. · Healthcare
2.9%
₹1,160
+2.19%
IPCALAB
Ipca Laboratories Ltd. · Healthcare
2.8%
₹2,009.6
+1.99%
BIOCON
Biocon Ltd. · Healthcare
2.8%
₹385
+1.32%
MANKIND
Mankind Pharma Ltd. · Healthcare
2.6%
₹2,300.7
+0.03%
GLAND
Gland Pharma Ltd. · Healthcare
2.4%
₹2,961.9
+1.86%
SAILIFE
Sai Life Sciences Ltd. · Healthcare
2.2%
₹1,600.5
+3.55%
WOCKPHARMA
Wockhardt Ltd. · Healthcare
1.7%
₹2,086.1
+0.67%
AJANTPHARM
Ajanta Pharmaceuticals Ltd. · Healthcare
1.5%
₹3,563.6
+1.80%
ABBOTINDIA
Abbott India Ltd. · Healthcare
1.4%
₹27,270
+5.25%
PPLPHARMA
Piramal Pharma Ltd. · Healthcare
1.3%
₹208.16
+1.69%
ETFs tracking this index
1 fund
Index levels are informational only, not investment advice.
Abbott India stock rallies as investors respond to strong recent earnings
Abbott India stock rallied over 5% on September 18, 2026, reaching an intraday high of INR 27,490. Investors responded to strong recent earnings, with the company reporting high single-digit revenue growth and double-digit net profit expansion in its latest quarter. The stock outperformed its sector peers, supported by positive technical indicators.
Taro Pharmaceutical Industries stock gains on Sun Pharma merger cash offer
Taro Pharmaceutical Industries stock is gaining as a cash merger with Sun Pharmaceutical Industries is finalized. Shareholders will receive $32.25 per share as of September 17, 2026, converting equity into a fixed cash payout. This move aligns with Sun Pharma's strategy to consolidate subsidiaries and streamline its corporate structure.
Is Laurus (LAURUSLABS.NS) Still a Buy After +2.24% Rally? 2026-09-17 - VOLD Alert
siam.in · 1 day ago
Mankind Pharma Q2 FY27 Earnings Preview
Mankind Pharma's Q2 FY27 earnings date is not yet confirmed, though Indian regulations require results by November 14, 2026. The company's stock traded at Rs 2,250.00 on September 17, 2026, up 0.18%. Investors will compare Q2 FY27 results against Q1 FY27 net profit of Rs 574.00 crore and Q2 FY26 profit of Rs 520.00 crore.
Pharma sector stocks today, September 17: Panacea Biotech gains 2.27%, Alembic Pharma up 2.13%, Wockhardt rises 2%
Wockhardt Limited's stock rose 2.01% to ₹2,062 during early trading on September 17. This increase contributed to an overall positive trend in the pharma sector, with the healthcare index trading 0.60% higher. Several other pharma stocks also saw gains, though some large counters faced pressure.
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?
The Economic Times · 3 days ago
Aurobindo Pharma shares fall 2% after USFDA issues one observation for Telangana facility
Moneycontrol.com · 3 days ago